150 participants
PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2026-08-20
- Start Date:
- 2025-10-20
- Completion:
- 2026-12-31
Conditions
- Lung Cancer
- Rechallenge
- Checkpoint Inhibitor Pneumonitis
Interventions
- DRUG
No Results Yet